The aim of the present study is to examine the effect of neuropeptide Y and estrogen on type IIb sodiumcoupled phosphate co-transporter (NaP i -IIb) gene expression and activity. Uptake studies with human intestinal cell line, Caco-2 cells, showed that treatment with neuropeptide Y and estrogen concentration-dependently increased sodiumdependent phosphate absorption. Reverse transcriptase-polymerase chain reaction analysis indicated that expression of NaP i -IIb mRNA was also increased after Y treatment with neuropeptide and estrogen. These studies show for the first time that neuropeptide Y increased intestinal sodium-dependent phosphate absorption. This increase is associated with the increase of the expression of NaP i -IIb mRNA.
INTRODUCTION
Intestinal phosphate (P i ) absorption across the apical membrane of small intestinal epithelial cells is mediated by the type IIb Na-coupled phosphate co-transporter (NaP i -IIb). The cDNA encoding this transporter has been cloned from several species, including human [1, 2] , rat [3] and mouse [4] . Intestinal P i absorption through the NaP i -IIb is regulated by various physiological effectors. Epidermal growth factor [5] and glucocorticoids [6] inhibit intestinal sodiumdependent P i absorption and NaP i -IIb gene expression, whereas dietary P i deprivation stimulates intestinal sodiumdependent P i absorption and NaP i -IIb gene expression [7] . Previously, vitamin D had been considered as an essential factor for adaptation of intestinal NaP i IIb to dietary P i deficiency. However, Segawa et al. [8] recently demonstrated that intestinal NaP i -IIb adaptation to a low-P i diet occurs independently of vitamin D using vitamin D receptor null mice. The critical factor(s) for upregulation of intestinal NaP i IIb for adaptation to a low-P i diet have not been clarified yet.
Renal P i reabsorption is mediated by the type IIa and type IIc sodium-coupled phosphate co-transporters located in the apical membrane of the proximal tubule [1, 4, 9, 10] . Recently, Mulroney et al. [11] reported that NaP i -II-like transporters in the brain are regulated by both dietary P i and cerebrospinal fluid P i concentrations, and that the central P i milieu can regulate renal NaP i -2 expression. This report implies that a factor derived from central nervous system may help regulate whole body P i homeostasis.
Neuropeptide Y is a potent orexigenic peptide that is implicated in the feeding response to a variety of stimuli *Address correspondence to this author at the Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences. 9-1 Shirokane 5-chome, Minato-ku, Tokyo 108-8641, Japan; Tel: +81-3-3444-6205; Fax: +81-3-3444-6205; E-mail: sakamotok@pharm.kitasato-u.ac.jp [12] . Neuropeptide Y is known to modulate both central and peripheral control of gastrointestinal motility [13, 14] , and is found in sympathetic nerve fibers together with norepinephrine [15] . Subcellular fragmentation experiments suggest that neuropeptide Y and norepinephrine are colocalized in large dense-core vesicles [16] . In addition, neuropeptide Y gene expression, storage, and release are all increased after sympathetic nerve activation such as seen during hypoglycemia [17] . In the guinea-pig gut, neuropeptide Y immunoreactivity is found in 25% of all submucosal neurons, many of which innervate the intestinal mucosa and have been traced to epithelial cells [18, 19] . These facts raised the possibility that neuropeptide Y may be a factor which regulates Na-dependent P i uptake in intestine. However, there is no evidence to date demonstrating regulation of NaP i -IIb expression via neuropeptide Y. Previous results have shown that Caco-2 cells endogenously express the NaP i -IIb gene [5] . Thus, the current studies were designed to investigate the possible link between neuropeptide Y and intestinal NaP i -IIb expression using Caco-2 cells. To determine the reasonability of the experimental system in the present study, the effect of estrogen, which is known to upregulate NaP i -IIb expression in the rat [20] , was also tested.
MATERIAL AND METHODS

Cell Culture
Human intestinal epithelial Caco-2 cells were grown as a monolayer in Dulbecco's-modified Eagle medium with 10% fetal bovine serum, 1% GlutaMax (Invitrogen, Carlsbad, CA) and 1% HyQ-MEM (HyClone, Logan, UT). The cells were cultured at 37°C in a humidified atmosphere containing 5% CO 2 . When cells became confluent, the medium was aspirated and changed to HEPES-buffered Krebs buffer comprised of (in mM) 137 NaCl, 4.8 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 10 Glucose, 10 HEPES, pH 7.0 adjusted with NaOH, and 0.1 -10 nM neuropeptide Y (Peptide Institute, Osaka, Japan), 10 -1000 nM -estradiol (Sigma, St. Louis, MO) or vehicle (phosphate buffer saline) was added 24 h before the start of experiments.
Phosphate Uptake Studies with Intact Cells
Cells grown in 12-well plates with or without treatment with the drug were washed 3 times with phosphate uptake buffer comprised of (in mM) 137 NaCl, 4.8 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 10 HEPES, pH 7.0 adjusted with Tris base, and afterwards incubated with 1 ml of the same buffer with 500 M KH 2 PO 4 and [ 32 P] KH 2 PO 4 (1 μCi/ml). After 15 min, the uptake buffer was removed and the cells were washed 3 times with ice-cold stop buffer comprised of (in mM) 137 NaCl, 10 HEPES, pH 7.0 adjusted with Tris base, and lysed with 2N NaOH. The lysate was used for scintillation counting and determination of protein concentration according to Lowry et al. [21] . To determine the sodiumindependent P i transport, NaCl in the uptake buffer was replaced by choline chloride in some experiments.
Semi-Quantitative Reverse Transcriptase-Polymerase Chain Reaction Analysis of NaP i -IIb Gene Expression in Caco-2 Cells
Total RNA was purified from Caco-2 cells using the Trizol reagent (Invitrogen), and reverse transcribed with SuperScript II reverse transcriptase (Invitrogen) for 60 min at 42°C primed with oligo(DT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen) at conditions recommended by the manufacturer. Polymerase chain reaction (PCR) was performed with ExTaq DNA polymerase (Takara Bio, Otsu, Japan) using a programmable thermal cycler (PTC-100, MJ Research, Waltham, MA). Primers for amplication of human NaP i IIb (sense 5'-TGCTCTTGCCCGTGGAGGTG-3'; antisense 5'-CCTCA ATGCATTGCCAGGGCT-3') were purchased from Nihon Gene Research Laboratories (Sendai, Japan). As an internal control, -actin DNA was amplified using its specific primers (sense 5'-GTGGGCCGCCCTAGGCACCA-3'; antisense 5'-TTAATGTCACGCACGATTTC-3'; Nihon Gene Research Laboratories). The PCR conditions were as following; 34 cycles of 94°C for 30 s, 65°C for 30 s and 68°C for 1 min for NaP i IIb, and 34 cycles of 94°C for 30 s, 60°C for 30 s and 68°C for 1 min for -actin. Subsaturation levels of cDNA templates that were needed to produce a dose-dependent amount of PCR product were defined in pilot experiments by testing a range of template concentrations. Subsequent PCR was carried out with subsaturation levels of RT reactions with identical amplification parameters. PCR was performed with human NaP i -IIb or -actin primers in separate reactions; equal volumes (10 μl) of the PCR products were separated on a TBE -1.5% agarose gel and stained with 0.1% ethidium bromide. The density of the bands was analyzed with Image J (National Institute of Health, Bethesda, MD). NaP i -IIb mRNA expression levels were estimated by taking a ratio of NaP i -IIb to -actin amplicon optical densities.
Statistical Analysis
Each datum is expressed as a mean ± S.E.M. One way analysis of variance followed by Bonferroni's post-hoc test was used for multiple comparisons. Differences were considered to be statistically significant when the P value was less than 0.05.
RESULTS AND DISCUSSION
To determine the reasonability of the experimental system in the present study, we tested the effect of estrogen, which is known to upregulate NaP i -IIb expression in the rat [20] . NaP i -IIb gene expression was concentrationdependently increased in the -estradiol-treated Caco-2 cells (Fig. 1A) . The mRNA levels in 100 nM -estradiol-treated cells are about 1.6-fold relative to the control cells and this result is quite consistent with that in a previous report [20] . That in 1 μM -estradiol-treated cells is about 2-fold. Nadependent P i absorption was also measured in -estradioltreated Caco-2 cells. Treatment with -estradiol induced a significant increase of Na-dependent P i absorption, whereas Na-independent P i absorption was not affected (Fig. 1B) . Compared with vehicle-treated cells, Na-dependent P i uptake increased about 20% in 1 μM -estradiol-treated cells. This result is consistent with that found on intestinal brush-border membrane vesicles from -estradiol-treated rats [20] . Based on these observations, the experimental system used in the present study is suitable for determination of the factors for regulation of intestinal NaP i -IIb gene expression and activity. Fig. (1) . Effect of -estradiol on NaP i -IIb mRNA levels and activity in human intestinal epithelial (Caco-2) cells. Caco-2 cells were grown in vehicle-containing medium or -estradiol-containing HEPES-buffered Krebs buffer (10 -1000 nM) for 24 h. Total RNA was then isolated from these cells and used for cDNA synthesis. NaP i -IIb gene expression was concentration-dependently increased in the neuropeptide Y-treated Caco-2 cells (Fig.  2A) . The mRNA levels in 1 nM neuropeptide Y-treated cells are about 1.7-fold relative to the control cells. Na-dependent P i absorption was also measured in neuropeptide Y-treated Caco-2 cells. Treatment with neuropeptide Y induced a significant increase of Na-dependent P i absorption, whereas Na-independent P i absorption was not affected (Fig. 2B) . Compared with the vehicle-treated cells, Na-dependent P i uptake for 15 min increased about 20% in 1 nM neuropeptide Y-treated cells. These results suggest that neuropeptide Y increases both the expression of NaP i -IIb mRNA and the activity of the co-transporter. The increase in Pi uptake is smaller than that in mRNA level of NaPi-IIb in the present study. Although the underlying mechanism is known, there are some possibilities; for example, (1) the protein level of NaPi-IIb may not be increased in proportion to mRNA level, (2) the measuring time of Pi uptake (for 15 min) is too long. In the previous report [20] , -estradiol induced a significant increase of Pi uptake when the measuring time is for 10 s, but did not show any increase when the measuring time is for 3 h. The increase in the number of the transporter will accelerate an initial rate of the uptake. When a measuring time is too long, the uptake will be saturated. It is possible that the measuring time in the present study is a little long to detect the difference of the initial uptake rate.
In the present study, neuropeptide Y showed similar results as estrogen, which is shown to increase NaPi-IIb expression in vivo [20] . Therefore, the results in the present study may suggest a physiological role of neuropeptide Y in the regulation of NaPi-IIb expression. However, the mechanism of the effect of neuropeptide Y is still unclear, because there are few commercially available ligands. According to Sgambati et al. [22] , Caco-2 cells express Y2 receptors. Therefore, Y2 receptor may be involved in the effects seen in the present study. Although there is no information about an acute direct activation of NaPi-IIb by neuropeptide Y, the possibility that the acute activation is involved in the increase of Pi uptake could not be excluded by the present study. Further studies are needed to confirm physiological relevance in animal models and the mechanism of the effects of neuropeptide Y.
Neuropeptide Y is known to be in sympathetic nerve fibers with norepinephrine [15] , and thought to be involved in the feeding response to a variety of stimuli [12] . Many neuropeptide Y neurons innervate the intestinal mucosa in the guinea-pig and have been traced to epithelial cells [18, 19] . The expression, storage and release of neuropeptide Y are all increased after sympathetic nerve is activated, for example during hypoglycemia [17] . From these facts, we hypothecated that neuropeptide Y released in the fasting period is possible to upregulate Na-dependent P i uptake to improve P i absorption in intestine.
Although the present study showed that neuropeptide Y increased intestinal sodium-dependent phosphate absorption, the specificity of the effect has been still unknown. It is possible that the effects of neuropeptide Y on other solutes uptakes influence the rate of uptake of phosphate. Further studies are needed to elucidate the specificity of the described effects of neuropeptide Y. We used human intestinal epithelial cell line, Caco-2 cells, as an in vitro model of intestine. Our results demonstrate that endogenous NaP i -IIb gene expression was stimulated by estrogen treatment in Caco-2 cells and the increase in NaP i -IIb mRNA abundance in Caco-2 cells after estrogen treatment is similar to the increase reported previously [20] , suggesting that the Caco-2 model used in the present study is very useful for investigating the mechanism regulating NaP i -IIb activity in intestine.
In summary, we show that neuropeptide Y increases intestinal Na-dependent P i uptake in Caco-2 cells at least in part through an increase of NaP i -IIb mRNA levels.
